Effect of sulfonylureas on the secretion of pancreatic immunoreactive glucagon and enteric glucagon-like immunoreactivity.
D000818:Animals; D000917:Antibody Formation; D000941:Antigens; D001120:Arginine / Q000378:metabolism; D005934:Glucagon / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism; D005905:Glyburide / Q000494:pharmacology; D066298:In Vitro Techniques; D007330:Insulin Antibodies / Q000032:analysis; D010179:Pancreas / Q000276:immunology / Q000378:metabolism*; D011863:Radioimmunoassay; D051381:Rats; D013453:Sulfonylurea Compounds / Q000494:pharmacology*; D013806:Theophylline / Q000494:pharmacology; D014044:Tolbutamide / Q000494:pharmacology
D000941:Antigens; D007330:Insulin Antibodies; D013453:Sulfonylurea Compounds; D005934:Glucagon; D001120:Arginine; D014044:Tolbutamide; D013806:Theophylline; D005947:Glucose; D005905:Glyburide